Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TAL1 Antikörper

TAL1 Reaktivität: Ratte IF, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7075819
  • Target Alle TAL1 Antikörper anzeigen
    TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
    Reaktivität
    • 81
    • 37
    • 26
    • 6
    • 6
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    Ratte
    Wirt
    • 83
    • 7
    Kaninchen
    Klonalität
    • 84
    • 6
    Polyklonal
    Konjugat
    • 49
    • 7
    • 7
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser TAL1 Antikörper ist unkonjugiert
    Applikation
    • 65
    • 44
    • 13
    • 9
    • 7
    • 6
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunofluorescence (IF), Immunohistochemistry (IHC)
    Kreuzreaktivität
    Ratte
    Aufreinigung
    Affinity purification
    Immunogen
    Recombinant protein corresponding to Mouse Tal1
    Top Product
    Discover our top product TAL1 Primärantikörper
  • Applikationshinweise
    IHC/IF (R) 1:800-1:1500/1:400-1:1000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    PBS, pH 7.4, 0.02 % sodium azide
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    -20 °C
  • Target
    TAL1 (T-Cell Acute Lymphocytic Leukemia 1 (TAL1))
    Andere Bezeichnung
    Tal1 (TAL1 Produkte)
    Synonyme
    SCL/tal-1 antikoerper, Scl antikoerper, bHLHa17 antikoerper, tal-1 antikoerper, SCL antikoerper, TCL5 antikoerper, scl antikoerper, tcl5 antikoerper, SCL-alpha antikoerper, SCL-beta antikoerper, scl/tal1 antikoerper, zgc:85605 antikoerper, T cell acute lymphocytic leukemia 1 antikoerper, TAL bHLH transcription factor 1, erythroid differentiation factor antikoerper, T-cell acute lymphocytic leukemia 1 S homeolog antikoerper, T-cell acute lymphocytic leukemia 1 antikoerper, Tal1 antikoerper, TAL1 antikoerper, tal1.S antikoerper, tal1 antikoerper
    Hintergrund
    Activation of TAL1 characterizes up to 60 % of cases of human T cell acute lymphoblastic leukemia, making it the most frequent gain-of-function mutation observed in this disorder. TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-helix transcription factor known to regulate embryonic hematopoiesis. This transcription factor binds as a heterodimer with E2A and HEB/HTF4 to a nucleotide sequence motif termed the E-box. In addition, leukemogenesis is accelerated dramatically by transgenic co-expression of TAL1 and the catalytic subunit of casein kinase alpha, a serine/ threonine protein kinase known to modulate the activity of other bHLH transcription factors.
    Gen-ID
    21349
    NCBI Accession
    NP_001274317
    UniProt
    P22091
    Pathways
    Stem Cell Maintenance
Sie sind hier: